Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 4;70(22):801-806.
doi: 10.15585/mmwr.mm7022a1.

Estimated Annual Number of HIV Infections ─ United States, 1981-2019

Estimated Annual Number of HIV Infections ─ United States, 1981-2019

Karin A Bosh et al. MMWR Morb Mortal Wkly Rep. .

Abstract

The first cases of Pneumocystis carinii (jirovecii) pneumonia among young men, which were subsequently linked to HIV infection, were reported in the MMWR on June 5, 1981 (1). At year-end 2019, an estimated 1.2 million persons in the United States were living with HIV infection (2). Using data reported to the National HIV Surveillance System, CDC estimated the annual number of new HIV infections (incidence) among persons aged ≥13 years in the United States during 1981-2019. Estimated annual HIV incidence increased from 20,000 infections in 1981 to a peak of 130,400 infections in 1984 and 1985. Incidence was relatively stable during 1991-2007, with approximately 50,000-58,000 infections annually, and then decreased in recent years to 34,800 infections in 2019. The majority of infections continue to be attributable to male-to-male sexual contact (63% in 1981 and 66% in 2019). Over time, the proportion of HIV infections has increased among Black/African American (Black) persons (from 29% in 1981 to 41% in 2019) and among Hispanic/Latino persons (from 16% in 1981 to 29% in 2019). Despite the lack of a cure or a vaccine, today's HIV prevention tools, including HIV testing, prompt and sustained treatment, preexposure prophylaxis, and comprehensive syringe service programs, provide an opportunity to substantially decrease new HIV infections. Intensifying efforts to implement these strategies equitably could accelerate declines in HIV transmission, morbidity, and mortality and reduce disparities.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE 1
FIGURE 1
Estimated HIV incidence among persons aged ≥13 years — United States, 1981–2019 Abbreviations: BCA = back-calculation approach; CD4 = CD4+ T-lymphocyte model; SEA = stratified extrapolation approach. * HIV incidence estimates for 1981–2006 were derived from the extended BCA applied to HIV surveillance data reported to CDC through June 2007. HIV incidence in 2007 was estimated using the SEA applied to HIV surveillance data reported to CDC through June 2011. HIV incidence estimates during 2008–2019 were derived from the CD4 model applied to HIV surveillance data reported to CDC through December 2020.
FIGURE 2
FIGURE 2
Estimated HIV incidence* among persons aged ≥13 years, by selected race/ethnicity and transmission category — United States, 1981–2019 Abbreviations: BCA = back-calculation approach; CD4 = CD4+ T-lymphocyte model; IDU = injection drug use; MMSC = male-to-male sexual contact; SEA = stratified extrapolation approach. * HIV incidence estimates for 1981–2006 were derived from the extended BCA applied to HIV surveillance data reported to CDC through June 2007. HIV incidence in 2007 was estimated using the SEA applied to HIV surveillance data reported to CDC through June 2011. HIV incidence estimates during 2008–2019 were derived from the CD4 model applied to HIV surveillance data reported to CDC through December 2020. Hispanic/Latino persons can be of any race. § Transmission categories assigned on the basis of sex at birth and include transgender persons. Data by transmission category have been adjusted to account for missing risk-factor information.

References

    1. CDC. Pneumocystis pneumonia—Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250–2.https://www.cdc.gov/mmwr/preview/mmwrhtml/lmrk077.htm - PubMed
    1. CDC. HIV surveillance data tables. Vol 2, no. 2. Core indicators for monitoring the Ending the HIV Epidemic initiative (early release): National HIV Surveillance System data reported through December 2020; and preexposure prophylaxis (PrEP) data reported through September 2020. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-2-n...
    1. Hall HI, Song R, Rhodes P, et al.; HIV Incidence Surveillance Group. Estimation of HIV incidence in the United States. JAMA 2008;300:520–9.10.1001/jama.300.5.520 - DOI - PMC - PubMed
    1. Song R, Hall HI, Green TA, Szwarcwald CL, Pantazis N. Using CD4 data to estimate HIV incidence, prevalence, and percent of undiagnosed infections in the United States. J Acquir Immune Defic Syndr 2017;74:3–9.10.1097/QAI.0000000000001151 - DOI - PubMed
    1. Purcell DW, Johnson CH, Lansky A, et al. Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. Open AIDS J 2012;6:98–107. 10.2174/1874613601206010098 - DOI - PMC - PubMed